$WEYS Balance Sheet | Understand Stock

$WEYS

$50.90 +$0.10 (0.2%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS:
Cash and cash equivalents
Investments, at fair value
Marketable securities, at amortized cost
Tariff refund receivable
Accounts receivable, net
Income tax receivable
Inventories
Prefunded dividend
Prepaid expenses and other current assets
Total current assets
Deferred income tax benefits
Property, plant and equipment, net
Operating lease right-of-use assets
Goodwill
Trademarks
Other assets
Total assets
LIABILITIES AND EQUITY:
Short-term borrowings
Accounts payable
Dividend payable
Operating lease liabilities
Accrued liabilities
Accrued income tax payable
Accrued compensation and employee benefits
Sales and advertising allowances
Taxes other than income taxes
Other
Total current liabilities
Deferred income tax liabilities
Long-term pension liability
Other long-term liabilities
Total liabilities
Common stock
Capital in excess of par value
Reinvested earnings
Accumulated other comprehensive loss
Total equity
Total liabilities and equity

Comments